Summary
Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: GHRP-6 is more often discussed in the realm of Metabolic and endocrine and Musculoskeletal health, whereas Melanotan I is more often associated with the realm of Dermatology and aesthetics. Both appear to work through Receptor agonist, but the functional emphasis still separates, with GHRP-6 leaning toward Anabolic growth and Lipolysis and fat loss and Melanotan I leaning toward Melanogenesis modulation. GHRP-6 has a more synthetic design origin, while Melanotan I is closer to synthetic analog background with GHRP-6 in Preclinical development and Melanotan I approved for Research use only. They are also usually discussed through the same administration routes, namely subcutaneous injection.